Cargando…
Prevalence of antibodies against SARS-CoV-2 in hemodialysis patients
Autores principales: | Arteaga-Müller, Giovanna Yazmin, Olivo-Gutierrez, Mara, Favela-Aragon, Karla Lizbeth, Hernández-Castillo, Paola Alejandra, Esquivel-Gomez, Victor, Camacho-Ortiz, Adrian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064699/ https://www.ncbi.nlm.nih.gov/pubmed/33893618 http://dx.doi.org/10.1007/s11255-021-02852-4 |
Ejemplares similares
-
Evaluation of hemodialysis vascular access involving multidisciplinary integration: Perspective from Latin America and Peru
por: Castillo Velarde, Edwin, et al.
Publicado: (2023) -
Effectiveness of COVID-19 vaccines in a large European hemodialysis cohort
por: Bernardo, Ana Paula, et al.
Publicado: (2022) -
SARS-CoV-2 neutralizing antibody response after three doses of mRNA1273 vaccine and COVID-19 in hemodialysis patients
por: Wang, Xiaoling, et al.
Publicado: (2022) -
Modifiable Risk Factors Are Important Predictors of COVID-19-Related Mortality in Patients on Hemodialysis
por: Kooman, Jeroen Peter, et al.
Publicado: (2022) -
Cure of Refractory Hypotension in a Hemodialysis Patient
por: Bhatta, Prajjwol D, et al.
Publicado: (2023)